Skip to content

Research at St Andrews

Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients

Research output: Research - peer-reviewArticle



Norbert Heinrich, Rodney Dawson, Jeannine du Bois, Kim Narunsky, Gary Horwith, Andrew J Phipps, Carol A Nacy, Rob E Aarnoutse, Martin J Boeree, Stephen H Gillespie, Amour Venter, Sonja Henne, Andrea Rachow, Patrick P J Phillips, Michael Hoelscher, Andreas H Diacon, on behalf of the Pan African Consortium for the Evaluation of Antituberculosis Antibiotics (PanACEA)

School/Research organisations


SQ109, an asymmetrical diamine, is a novel anti-TB drug candidate. This first study in patients was done to determine safety, tolerability, pharmacokinetics and bacteriological effect of different doses of SQ109 alone and in combination with rifampicin when administered over 14 days.


Original languageEnglish
JournalJournal of Antimicrobial Chemotherapy
StatePublished - 27 Jan 2015

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. A population pharmacokinetic model incorporating saturable pharmacokinetics and autoinduction for high rifampicin doses

    Svensson, R. J., Aarnoutse, R. E., Diacon, A. H., Dawson, R., Gillespie, S. H., Boeree, M. J. & Simonsson, U. S. H. 7 Aug 2017 In : Clinical Pharmacology & Therapeutics. 103, p. 674-683 10 p.

    Research output: Research - peer-reviewArticle

  2. Pseudomonas aeruginosa intensive care unit outbreak: winnowing of transmissions with molecular and genomic typing

    Parcell, B. J., Oravcova, K., Pinheiro, M., Holden, M. T. G., Phillips, G., Turton, J. F. & Gillespie, S. H. Mar 2018 In : Journal of Hospital Infection. 98, 3, p. 282-288 7 p.

    Research output: Research - peer-reviewArticle

  3. OMNIgene.SPUTUM suppresses contaminants whilst maintaining Mycobacterium tuberculosis viability and obviates cold-chain transport

    Azam, K., Cadir, N., Madeira, C., Gillespie, S. H. & Sabiiti, W. 16 Feb 2018 In : ERJ Open Research. 4, 8 p., 00074-2017

    Research output: Research - peer-reviewArticle

  4. Detecting phenotypically resistant Mycobacterium tuberculosis using wavelength modulated Raman spectroscopy

    Baron, V. O., Chen, M., Clark, S. O., Williams, A., Dholakia, K. & Gillespie, S. H. 2018 Antibiotic Resistance Protocols. Gillespie, S. (ed.). New York, NY: Humana Press/Springer, p. 41-50 10 p. (Methods in Molecular Biology; vol. 1736)

    Research output: ResearchChapter

Related by journal

  1. Has primary care antimicrobial use really been increasing? Comparison of changes in different prescribing measures for a complete geographic population 1995–2014

    Neilly, M. D. J., Guthrie, B., Hernandez Santiago, V., Vadiveloo, T., Donnan, P. T. & Marwick, C. A. 1 Oct 2017 In : Journal of Antimicrobial Chemotherapy. 72, 10, p. 2921-2930 10 p.

    Research output: Research - peer-reviewArticle

  2. Improved power for TB phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methods

    Svensson, R. J., Gillespie, S. H. & Simonsson, U. S. H. 1 Aug 2017 In : Journal of Antimicrobial Chemotherapy. 72, 8, p. 2311-2319 9 p.

    Research output: Research - peer-reviewArticle

  3. ST3268: a geographically widespread primate MRSA clone

    Hsu, L-Y., Holden, M. T. G., Koh, T. H., Pettigrew, K. A., Cao, D., Hon, P. Y., Sergio, D. M., Pena, E. & Ogden, B. E. 1 Aug 2017 In : Journal of Antimicrobial Chemotherapy. 72, 8, p. 2401-2403 2 p.

    Research output: Research - peer-reviewLetter

  4. Time series analysis of the impact of an intervention in Tayside, Scotland to reduce primary care broad-spectrum antimicrobial use

    Hernandez-Santiago, V., Marwick, C. A., Patton, A., Davey, P. G., Donnan, P. T. & Guthrie, B. 1 Aug 2015 In : Journal of Antimicrobial Chemotherapy. 70, 8, p. 2397-2404 8 p., dkv095

    Research output: Research - peer-reviewArticle

ID: 167131474